New York Life Investment Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,539
Closed -$380K 1082
2024
Q1
$380K Buy
3,539
+1,437
+68% +$143K ﹤0.01% 848
2023
Q4
$210K Sell
2,102
-57
-3% -$5.57K ﹤0.01% 1291
2023
Q3
$257K Sell
2,159
-332
-13% -$49.5K ﹤0.01% 1234
2023
Q2
$444K Sell
2,491
-387
-13% -$71K ﹤0.01% 829
2023
Q1
$475K Buy
2,878
+329
+13% +$56.6K 0.01% 1011
2022
Q4
$401K Buy
2,549
+288
+13% +$43.8K ﹤0.01% 1045
2022
Q3
$341K Buy
2,261
+166
+8% +$27.6K ﹤0.01% 1044
2022
Q2
$344K Buy
+2,095
New +$403K ﹤0.01% 1098

Other funds holding ICUI

New York Life Investment Management's ICUI Position: Q2 2024 in Review

New York Life Investment Management sold out of ICU Medical (ICUI) in Q2 2024, closing a stake of 3,539 shares — an estimated $380K sold.

New York Life Investment Management first reported a position in ICUI in Q2 2022 and held it in 8 quarters. The position peaked at $475K in Q1 2023. 255 funds tracked by Wall St. Rank hold ICUI as of Q2 2024.

  • New York Life Investment Management reported no remaining ICU Medical position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 3,539 ICU Medical shares in Q2 2024, an estimated $380K.
  • New York Life Investment Management first reported a position in ICU Medical in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's ICU Medical position peaked at $475K in Q1 2023.
  • 255 funds tracked by Wall St. Rank held ICU Medical as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.